تسجيل الدخول/ اشتراك

WATCH: Weight-loss giant Novo Nordisk's shares rose more than 5% to a high last hit in October, driven by ‘encouraging’ early US prescription data for its Wegovy pill, which the firm hopes will help it regain ground in the obesity drug race

١٧/٠١ ٠٠:٤٠
صاعد
سبحة

الأخبار الشائعة